145 related articles for article (PubMed ID: 28366190)
1. Structural characterization of As-MIF and hJAB1 during the inhibition of cell-cycle regulation.
Park YH; Jeong MS; Ha KT; Yu HS; Jang SB
BMB Rep; 2017 May; 50(5):269-274. PubMed ID: 28366190
[TBL] [Abstract][Full Text] [Related]
2. Intracellular action of the cytokine MIF to modulate AP-1 activity and the cell cycle through Jab1.
Kleemann R; Hausser A; Geiger G; Mischke R; Burger-Kentischer A; Flieger O; Johannes FJ; Roger T; Calandra T; Kapurniotu A; Grell M; Finkelmeier D; Brunner H; Bernhagen J
Nature; 2000 Nov; 408(6809):211-6. PubMed ID: 11089976
[TBL] [Abstract][Full Text] [Related]
3. Impaired DNA damage checkpoint response in MIF-deficient mice.
Nemajerova A; Mena P; Fingerle-Rowson G; Moll UM; Petrenko O
EMBO J; 2007 Feb; 26(4):987-97. PubMed ID: 17290223
[TBL] [Abstract][Full Text] [Related]
4. Macrophage migration inhibitory factor does not modulate co-activation of androgen receptor by Jab1/CSN5.
Berndt K; Kim M; Meinhardt A; Klug J
Mol Cell Biochem; 2008 Jan; 307(1-2):265-71. PubMed ID: 17786542
[TBL] [Abstract][Full Text] [Related]
5. Binding of JAB1/CSN5 to MIF is mediated by the MPN domain but is independent of the JAMM motif.
Burger-Kentischer A; Finkelmeier D; Thiele M; Schmucker J; Geiger G; Tovar GE; Bernhagen J
FEBS Lett; 2005 Mar; 579(7):1693-701. PubMed ID: 15757663
[TBL] [Abstract][Full Text] [Related]
6. Phosphorylation of p53 at threonine 155 is required for Jab1-mediated nuclear export of p53.
Lee EW; Oh W; Song HP; Kim WK
BMB Rep; 2017 Jul; 50(7):373-378. PubMed ID: 28539160
[TBL] [Abstract][Full Text] [Related]
7. Macrophage migration inhibitory factor (MIF) promotes cell survival by activation of the Akt pathway and role for CSN5/JAB1 in the control of autocrine MIF activity.
Lue H; Thiele M; Franz J; Dahl E; Speckgens S; Leng L; Fingerle-Rowson G; Bucala R; Lüscher B; Bernhagen J
Oncogene; 2007 Aug; 26(35):5046-59. PubMed ID: 17310986
[TBL] [Abstract][Full Text] [Related]
8. Rapid and transient activation of the ERK MAPK signalling pathway by macrophage migration inhibitory factor (MIF) and dependence on JAB1/CSN5 and Src kinase activity.
Lue H; Kapurniotu A; Fingerle-Rowson G; Roger T; Leng L; Thiele M; Calandra T; Bucala R; Bernhagen J
Cell Signal; 2006 May; 18(5):688-703. PubMed ID: 16122907
[TBL] [Abstract][Full Text] [Related]
9. The MIF homologue D-dopachrome tautomerase promotes COX-2 expression through β-catenin-dependent and -independent mechanisms.
Xin D; Rendon BE; Zhao M; Winner M; McGhee Coleman A; Mitchell RA
Mol Cancer Res; 2010 Dec; 8(12):1601-9. PubMed ID: 21071513
[TBL] [Abstract][Full Text] [Related]
10. S100A7, Jab1, and p27
Granata M; Skarmoutsou E; Gangemi P; Mazzarino MC; D'Amico F
J Cell Biochem; 2019 Mar; 120(3):3384-3392. PubMed ID: 30203426
[TBL] [Abstract][Full Text] [Related]
11. JAB1/CSN5 and the COP9 signalosome. A complex situation.
Chamovitz DA; Segal D
EMBO Rep; 2001 Feb; 2(2):96-101. PubMed ID: 11258719
[TBL] [Abstract][Full Text] [Related]
12. p53 mediates cigarette smoke-induced apoptosis of pulmonary endothelial cells: inhibitory effects of macrophage migration inhibitor factor.
Damico R; Simms T; Kim BS; Tekeste Z; Amankwan H; Damarla M; Hassoun PM
Am J Respir Cell Mol Biol; 2011 Mar; 44(3):323-32. PubMed ID: 20448056
[TBL] [Abstract][Full Text] [Related]
13. The D-dopachrome tautomerase (DDT) gene product is a cytokine and functional homolog of macrophage migration inhibitory factor (MIF).
Merk M; Zierow S; Leng L; Das R; Du X; Schulte W; Fan J; Lue H; Chen Y; Xiong H; Chagnon F; Bernhagen J; Lolis E; Mor G; Lesur O; Bucala R
Proc Natl Acad Sci U S A; 2011 Aug; 108(34):E577-85. PubMed ID: 21817065
[TBL] [Abstract][Full Text] [Related]
14. HIF1α-Induced by Lysophosphatidic Acid Is Stabilized via Interaction with MIF and CSN5.
No YR; Lee SJ; Kumar A; Yun CC
PLoS One; 2015; 10(9):e0137513. PubMed ID: 26352431
[TBL] [Abstract][Full Text] [Related]
15. Glucocorticoid counter regulation: macrophage migration inhibitory factor as a target for drug discovery.
Lolis E
Curr Opin Pharmacol; 2001 Dec; 1(6):662-8. PubMed ID: 11757824
[TBL] [Abstract][Full Text] [Related]
16. Jab1 Silencing Inhibits Proliferation and Sensitizes to Cisplatin in Biliary Tract Cancer.
Nam AR; Kim JW; Park JE; Bang JH; Jin MH; Oh DY; Bang YJ
Cancer Res Treat; 2019 Jul; 51(3):886-900. PubMed ID: 30282449
[TBL] [Abstract][Full Text] [Related]
17. The crucial p53-dependent oncogenic role of JAB1 in osteosarcoma in vivo.
Samsa WE; Mamidi MK; Bashur LA; Elliott R; Miron A; Chen Y; Lee B; Greenfield EM; Chan R; Danielpour D; Zhou G
Oncogene; 2020 Jun; 39(23):4581-4591. PubMed ID: 32390003
[TBL] [Abstract][Full Text] [Related]
18. Macrophage migration inhibitory factor directly interacts with hepatopoietin and regulates the proliferation of hepatoma cell.
Li Y; Lu C; Xing G; Zhu Y; He F
Exp Cell Res; 2004 Nov; 300(2):379-87. PubMed ID: 15475002
[TBL] [Abstract][Full Text] [Related]
19. Gfer inhibits Jab1-mediated degradation of p27kip1 to restrict proliferation of hematopoietic stem cells.
Teng EC; Todd LR; Ribar TJ; Lento W; Dimascio L; Means AR; Sankar U
Mol Biol Cell; 2011 Apr; 22(8):1312-20. PubMed ID: 21346186
[TBL] [Abstract][Full Text] [Related]
20. Thioredoxin modulates activator protein 1 (AP-1) activity and p27Kip1 degradation through direct interaction with Jab1.
Hwang CY; Ryu YS; Chung MS; Kim KD; Park SS; Chae SK; Chae HZ; Kwon KS
Oncogene; 2004 Nov; 23(55):8868-75. PubMed ID: 15480426
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]